Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
1 hedge funds and large institutions have $468K invested in Albany Molecular Research Inc in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
86% less capital invested
Capital invested by funds: $3.44M → $468K (-$2.97M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$2.97M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| $468K | – | – | – |
|
|
AA
2
Ancora Advisors
Cleveland,
Ohio
| – | -$2.97M | -136,400 | Closed |
|
AMRI Hedge Fund Activity: Q4 2017 in Review
1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2017, worth a combined $468K — down 86% from $3.44M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AMRI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Ancora Advisors, exiting entirely with an estimated $2.97M sold.
- 1 institutional investor held Albany Molecular Research Inc (AMRI) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $468K of Albany Molecular Research Inc stock for Q4 2017, down 86% quarter-over-quarter.
- 0 funds opened new Albany Molecular Research Inc positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest Albany Molecular Research Inc seller in Q4 2017 was Ancora Advisors, an estimated $2.97M sold.
Based on aggregated 13F filings for Q4 2017.